Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy
Background/Purpose: Shared decision-making (SDM) promotes patient awareness about medical conditions and treatments, facilitating patient involvement in care decisions. This two-stage multicenter study evaluated impacts of SDM in Taiwanese adults with atrial fibrillation (AF) eligible for novel oral...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Journal of the Formosan Medical Association |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664624004042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850037204274905088 |
|---|---|
| author | Yen-Wen Wu Tsung-Hsien Lin Yuan-Po Yang Wei-Tsung Wu Chung-Ming Tu Hung-Kain Huang Chun-Yuan Chu Chi-Cheng Huang Szu-Chi Chien Shih-Jie Jhuo Ching-Pei Chen |
| author_facet | Yen-Wen Wu Tsung-Hsien Lin Yuan-Po Yang Wei-Tsung Wu Chung-Ming Tu Hung-Kain Huang Chun-Yuan Chu Chi-Cheng Huang Szu-Chi Chien Shih-Jie Jhuo Ching-Pei Chen |
| author_sort | Yen-Wen Wu |
| collection | DOAJ |
| description | Background/Purpose: Shared decision-making (SDM) promotes patient awareness about medical conditions and treatments, facilitating patient involvement in care decisions. This two-stage multicenter study evaluated impacts of SDM in Taiwanese adults with atrial fibrillation (AF) eligible for novel oral anticoagulant (NOAC) therapy. Methods: Participants were NOAC-naïve (part I) or dabigatran-experienced (part II). During Stage I, part I participants (n = 124) completed a semi-structured survey (understanding evaluation sections only) before and after viewing SDM materials on stroke prevention for AF. Surveys collected data on anxiety about AF, confidence in healthcare professionals, usefulness of the SDM materials, and perception of different NOACs. During Stage II, part I participants after being prescribed NOACs, and part II participants completed another survey to compare impacts of SDM. Results: During Stage I, dabigatran was the preferred NOAC after viewing the SDM materials among 90% of part I participants. During Stage II, both part I (n = 87) and part II participants (n = 104) completed another survey. Fewer part I participants were anxious about AF (p < 0.01), and more had confidence in healthcare professionals (p < 0.01) after viewing SDM materials than before. Most part I participants (≥90%) rated the SDM materials as “very helpful”. In Stage II, participants viewing SDM before initiating dabigatran had lower anxiety (part I, 43%; part II, 53%; p < 0.01) and a higher trust (part I, 92%; part II, 84%; p < 0.01). Conclusion: In conclusion, SDM reduced anxiety and improved trust in healthcare professionals among NOAC-naïve participants with AF. |
| format | Article |
| id | doaj-art-b4045a71d80a491aae0731c47ae01ce9 |
| institution | DOAJ |
| issn | 0929-6646 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of the Formosan Medical Association |
| spelling | doaj-art-b4045a71d80a491aae0731c47ae01ce92025-08-20T02:56:55ZengElsevierJournal of the Formosan Medical Association0929-66462025-03-01124322723310.1016/j.jfma.2024.08.036Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapyYen-Wen Wu0Tsung-Hsien Lin1Yuan-Po Yang2Wei-Tsung Wu3Chung-Ming Tu4Hung-Kain Huang5Chun-Yuan Chu6Chi-Cheng Huang7Szu-Chi Chien8Shih-Jie Jhuo9Ching-Pei Chen10Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; PhD Program in Tissue Engineering and Regenerative Medicine, National Chung-Hsing University and National Health Research Institutes, Taichung, Taiwan; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan Miaoli, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, TaiwanDivision of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, TaiwanDivision of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, TaiwanDivision of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan; Corresponding author. Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.Background/Purpose: Shared decision-making (SDM) promotes patient awareness about medical conditions and treatments, facilitating patient involvement in care decisions. This two-stage multicenter study evaluated impacts of SDM in Taiwanese adults with atrial fibrillation (AF) eligible for novel oral anticoagulant (NOAC) therapy. Methods: Participants were NOAC-naïve (part I) or dabigatran-experienced (part II). During Stage I, part I participants (n = 124) completed a semi-structured survey (understanding evaluation sections only) before and after viewing SDM materials on stroke prevention for AF. Surveys collected data on anxiety about AF, confidence in healthcare professionals, usefulness of the SDM materials, and perception of different NOACs. During Stage II, part I participants after being prescribed NOACs, and part II participants completed another survey to compare impacts of SDM. Results: During Stage I, dabigatran was the preferred NOAC after viewing the SDM materials among 90% of part I participants. During Stage II, both part I (n = 87) and part II participants (n = 104) completed another survey. Fewer part I participants were anxious about AF (p < 0.01), and more had confidence in healthcare professionals (p < 0.01) after viewing SDM materials than before. Most part I participants (≥90%) rated the SDM materials as “very helpful”. In Stage II, participants viewing SDM before initiating dabigatran had lower anxiety (part I, 43%; part II, 53%; p < 0.01) and a higher trust (part I, 92%; part II, 84%; p < 0.01). Conclusion: In conclusion, SDM reduced anxiety and improved trust in healthcare professionals among NOAC-naïve participants with AF.http://www.sciencedirect.com/science/article/pii/S0929664624004042Atrial fibrillationAnticoagulantsDecision makingSharedNovel oral anti-coagulantsTaiwan |
| spellingShingle | Yen-Wen Wu Tsung-Hsien Lin Yuan-Po Yang Wei-Tsung Wu Chung-Ming Tu Hung-Kain Huang Chun-Yuan Chu Chi-Cheng Huang Szu-Chi Chien Shih-Jie Jhuo Ching-Pei Chen Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy Journal of the Formosan Medical Association Atrial fibrillation Anticoagulants Decision making Shared Novel oral anti-coagulants Taiwan |
| title | Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy |
| title_full | Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy |
| title_fullStr | Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy |
| title_full_unstemmed | Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy |
| title_short | Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy |
| title_sort | impact of shared decision making in taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy |
| topic | Atrial fibrillation Anticoagulants Decision making Shared Novel oral anti-coagulants Taiwan |
| url | http://www.sciencedirect.com/science/article/pii/S0929664624004042 |
| work_keys_str_mv | AT yenwenwu impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT tsunghsienlin impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT yuanpoyang impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT weitsungwu impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT chungmingtu impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT hungkainhuang impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT chunyuanchu impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT chichenghuang impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT szuchichien impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT shihjiejhuo impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy AT chingpeichen impactofshareddecisionmakingintaiwanesepatientswithatrialfibrillationeligiblefornoveloralanticoagulanttherapy |